Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05152238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ITP Registry and Accompanying Biospecimen Collection

Study acronym: ITP-Registry
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 15, 2025 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study sites: 62 to 64v6
  2. Study sites: 61 to 62v5
  3. Re-verified, no change to tracked fieldsv4
  4. Study sites: 1 to 61v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
Trial Details
NCT Number NCT05152238
Lead Sponsor Jena University Hospital
Collaborators: University Hospital Dresden, Novartis, Swedish Orphan Biovitrum, Grifols Biologicals, LLC, Amgen, argenx
Conditions
(from sponsor)		 Immune Thrombocytopenia
Related terms Purpura, Thrombocytopenic, Idiopathic
Enrollment 1,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov